HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal Neovascularization

New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
Also Known As:
Angiogenesis, Corneal; Corneal Neovascularizations; Neovascularization, Corneal; Neovascularizations, Corneal; Corneal Angiogenesis
Networked: 1297 relevant articles (131 outcomes, 210 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Burns
2. Choroidal Neovascularization
3. Inflammation (Inflammations)
4. Keratitis
5. Chemical Burns (Chemical Burn)

Experts

1. Cursiefen, Claus: 40 articles (01/2022 - 10/2002)
2. Bock, Felix: 27 articles (06/2021 - 06/2007)
3. Azar, Dimitri T: 24 articles (01/2020 - 01/2003)
4. Chang, Jin-Hong: 24 articles (01/2020 - 01/2003)
5. Dana, Reza: 17 articles (01/2022 - 07/2006)
6. Ambati, Balamurali K: 16 articles (01/2017 - 08/2002)
7. Usui, Tomohiko: 15 articles (10/2020 - 11/2004)
8. Chung, Sung Kun: 14 articles (12/2016 - 01/2010)
9. Hos, Deniz: 13 articles (01/2022 - 05/2008)
10. Lu, Peirong: 12 articles (01/2021 - 02/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Corneal Neovascularization:
1. Bevacizumab (Avastin)FDA Link
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
3. AlkaliesIBA
4. afliberceptIBA
5. Verteporfin (Visudyne)FDA Link
6. Ranibizumab (Lucentis)FDA Link
7. 1-phenyl-3,3-dimethyltriazene (PDT)IBA
8. Dexamethasone (Maxidex)FDA LinkGeneric
9. Ophthalmic Solutions (Eye Drops)IBA
10. Doxycycline (Periostat)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Photochemotherapy (Photodynamic Therapy)
3. Penetrating Keratoplasty
4. Injections
5. Topical Administration